Delivery Order SPE2DB25D3504-SPE2DB25FVVVJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,110.58 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 50 mg tablets (30-count) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price delivery order issued without a set-aside designation, indicating competitive award under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal XR 300 mg tablets (30-count units) under a firm fixed-price contract on July 2, 2025, with a ceiling value of $4,382.36 and an ultimate completion date of July 3, 2025. This award represents a non-competitive set-aside delivery order issued from AmerisourceBergen's existing DLA contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a Firm Fixed Price delivery order valued at $10,187.98 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.99 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 50 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,310.81 to AmerisourceBergen Drug Corp for Lamictal XR 250 mg tablets (30-count units) on August 1, 2025, with a completion deadline of August 4, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lamictal XR (lamotrigine extended-release) is an anticonvulsant medication commonly used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) under a firm fixed-price contract valued at $5,644.62, with an ultimate completion date of April 28, 2025. This non-competitive, non-set-aside delivery order represents a standard pharmaceutical procurement transaction sourced from AmerisourceBergen's extensive federal contract portfolio. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $42,766.34 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,389.64 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 300 mg tablets (30-count) under a firm fixed price contract type. The award, made on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $8,951.56 delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Lamictal XR 300 mg tablets, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal XR 250 mg tablets (30-count units) with a ceiling value of $44,995.65 under a firm fixed price contract type. The award, issued on May 12, 2025, with an ultimate completion date of May 13, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVVJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal XR 50 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $4,466.95. The award, issued on August 4, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantially larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999 million through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Lamictal XR is a neurological medication used to treat seizure disorders and bipolar disorder, reflecting the type of specialty pharmaceutical commodities routinely procured through the DLA Medical Supply Chain to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 8/4/25 |